Efficacy and Safety Dose Finding Study of Givinostat to Treat Polyarticular Course Juvenile Idiopathic Arthritis

PHASE2TerminatedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

June 30, 2012

Study Completion Date

March 31, 2013

Conditions
Polyarticular Course Juvenile Idiopathic Arthritis
Interventions
DRUG

Givinostat

1.0 mg/kg daily (0.5 mg/kg twice a day) in fed condition 1.5 mg/kg daily (0.75 mg/kg twice a day) in fed condition

Trial Locations (13)

9000

Universitair Ziekenhuis Gent, Ghent

11000

Institute of Rheumatology Belgrade, Belgrade

11070

"Mother and Child Health Institute Dr Vukan Cupic", New Belgrade

12109

1st Faculty of Medicine and General Faculty Hospital, Prague

18000

University Clinical Center Nis, Niš

20122

Istituto Gaetano Pini, Milan

28034

Hospital Ramón y Cajal, Madrid

35128

Azienda Ospedaliera-Università di Padova, Padua

50139

Ospedale Meyer, Florence

98125

Policlinico G. Martino, Messina

020395

"Institutul pentru Ocrotirea Mamei si Copilului Alfred Rusescu", Bucharest

041451

"Spitalul Clinic de Urgenta pentru Copii M.S. Curie", Bucharest

SI-1000

Children's Hospital - University Medical Centre Ljubljana, Ljubljana

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Italfarmaco

INDUSTRY